You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日總結》恆指跌324點 科指跌逾3% 京東創新低
科網股受壓拖累港股早市下跌。恆指低開56點後跌幅擴大,半日跌324點或1.6%,報19,635點;國指跌127點或1.9%,報6,606點;恆生科技指數跌137點或3.5%,報3,824點。大市半日成交總額524.43億元,滬、深港通南下交易半日淨流入15.19億及12.23億元人民幣。 市場繼續關注中美關係發展,科技股下滑,阿里(09988.HK)跌3.3%報84.05元,騰訊(00700.HK)跌2.2%報337.4元,美團(03690.HK)、京東(09618.HK)、網易(09999.HK)及快手(01024.HK)跌3.8%至4.8%,其中京東曾見132.2元在港上市新低。嗶哩嗶哩(09626.HK)跌5.3%。據報百度(09888.HK)啟動文心一言企業服務內測,但股價隨大市跌4.1%。 此外,美圖(01357.HK)、微盟(02013.HK)、萬國數據(09698.HK)及騰訊音樂(01698.HK)跌4%至4.8%,金山雲(03896.HK)及東方甄選(01797.HK)跌6.2%及5.1%。手機部件股舜宇(02382.HK)、鴻騰(06088.HK)及比亞迪電子(00285.HK)跌逾4%,高偉電子(01415.HK)跌5.7%。 醫藥股顯著下跌,石藥(01093.HK)、中生製藥(01177.HK)及信達生物(01801.HK)跌逾4%,石四藥(02005.HK)、復星醫藥(02196.HK)、金斯瑞(01548.HK)及康希諾(06185.HK)跌6.1%至8.3%。藥明康德(02359.HK)首季淨利增32%,股價高開後倒跌8.5%,同系藥明生物(02269.HK)跌6.3%。 智利決定國有化鋰工業引發鋰供應憂慮,贛鋒鋰業(01772.HK)及天齊鋰業(09696.HK)挫8.3%及7%。電池股中創新航(03931.HK)跌5.6%。汽車股亦受拖累,零跑(09863.HK)及長汽(02333.HK)跌6.2%及4.5%,比亞迪(01211.HK)、理想(02015.HK)及蔚來(09866.HK)跌3%至3.1%。華晨中國(01114.HK)稱不知悉瀋陽市政府可能收購公司股份事宜,股價回吐1.2%。 消費股方面,旅遊平台同程(00780.HK)及攜程(09961.HK)跌逾3%,電影票平台貓眼娛樂(01896.HK)跌4.4%,啤酒股百威亞太(01876.HK)跌3.2%。青島啤酒(00168.HK)首季淨利增長29%,股價高開後隨大市倒跌1.7%。紙業股玖紙(02689.HK)半日挫逾9%。 其他股份方面,匯控(00005.HK)跌0.4%報55.7元,港交所(00388.HK)跌1.5%,友邦(01299.HK)升0.2%報82.6元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account